Roccatello, D.; Fenoglio, R.; Naretto, C.; Baldovino, S.; Sciascia, S.; Ferro, M.; Rossi, D.
Daratumumab Monotherapy in Severe Patients with AL Amyloidosis and Biopsy-Proven Renal Involvement: A Real Life Experience. J. Clin. Med. 2020, 9, 3232.
https://doi.org/10.3390/jcm9103232
AMA Style
Roccatello D, Fenoglio R, Naretto C, Baldovino S, Sciascia S, Ferro M, Rossi D.
Daratumumab Monotherapy in Severe Patients with AL Amyloidosis and Biopsy-Proven Renal Involvement: A Real Life Experience. Journal of Clinical Medicine. 2020; 9(10):3232.
https://doi.org/10.3390/jcm9103232
Chicago/Turabian Style
Roccatello, Dario, Roberta Fenoglio, Carla Naretto, Simone Baldovino, Savino Sciascia, Michela Ferro, and Daniela Rossi.
2020. "Daratumumab Monotherapy in Severe Patients with AL Amyloidosis and Biopsy-Proven Renal Involvement: A Real Life Experience" Journal of Clinical Medicine 9, no. 10: 3232.
https://doi.org/10.3390/jcm9103232
APA Style
Roccatello, D., Fenoglio, R., Naretto, C., Baldovino, S., Sciascia, S., Ferro, M., & Rossi, D.
(2020). Daratumumab Monotherapy in Severe Patients with AL Amyloidosis and Biopsy-Proven Renal Involvement: A Real Life Experience. Journal of Clinical Medicine, 9(10), 3232.
https://doi.org/10.3390/jcm9103232